Results 251 to 260 of about 65,572 (317)

Outcomes of surgical management for Kommerell's diverticulum associated with type B aortic dissection. [PDF]

open access: yesInterdiscip Cardiovasc Thorac Surg
Ahmad N   +5 more
europepmc   +1 more source

Impact of Point‐of‐Care Ultrasound in Medicalized Prehospital Setting on Diagnostic Workup

open access: yesJournal of Ultrasound in Medicine, Volume 45, Issue 5, Page 985-990, May 2026.
Objectives The primary objective of this study was to describe the indications for performing point‐of‐care ultrasound (POCUS) in prehospital settings. The secondary objective was to assess its impact on the diagnostic workup when its use was initiated by the emergency physician (EP) dispatched with a mobile intensive care unit (MICU).
Frederic Balen   +2 more
wiley   +1 more source

Techniques of liver transplantation [PDF]

open access: yes, 2000
Casavilla, A, Gordon, RD, Starzl, TE
core  

Innate Lymphoid Cells in Tissue Homeostasis and Diseases

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Innate lymphoid cells (ILCs) are a heterogeneous group of immune cells with phenotypic and functional plasticity. ILCs dynamically regulate various immune cell types and play a crucial role in the pathophysiological processes of specific organs during sepsis. Targeting ILCs is a promising strategy for treating sepsis.
Zhenzhen Zhan   +7 more
wiley   +1 more source

Heterogeneous Myocardial Adaptation to Pressure Overload Reveals a Spared, Vulnerable Segment Identified by Multiparametric Cardiac MRI

open access: yesNMR in Biomedicine, Volume 39, Issue 5, May 2026.
Graphical summary of a longitudinal multiparametric MRI study in mouse TAC model, showing imaging at baseline, 3 days, 4 weeks and 7 weeks. All TAC animals developed global LV hypertrophy (+62% LV mass at week 7), but half displayed a spared‐hypertrophy basolateral region.
Vitali Koch   +6 more
wiley   +1 more source

Hederagenin Attenuates Cardiac Remodeling by Targeting Phosphodiesterase 9A

open access: yesPhytotherapy Research, Volume 40, Issue 5, Page 2710-2729, May 2026.
ABSTRACT Background and Aim New therapeutic strategies for heart failure are urgently needed. The protective effects of cyclic guanosine monophosphate (cGMP)—protein kinase G (PKG) pathway on heart have been widely reported. Despite phosphodiesterase 9A (PDE9A) inhibitors combating cardiac remodeling, clinically available drugs are lacking. Hederagenin
Liqian Chen   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy